Library
My List
My List
Loading items...
Go to my list
Log In
Log in with your UoM account
Problems logging in with your UoM account?
or
Guest login
Email address
Password
No UoM account? Click here to register a guest account.
Have you forgotten your guest credentials?
Library
Staff
Alumni
Library
LMS
Handbook
Contact and maps
FAQs
Communities & Collections
Browse Repository
Statistics
My Lists
search
Search
My List
My List
Loading items...
Go to my list
Log In
Log in with your UoM account
Problems logging in with your UoM account?
or
Guest login
Email address
Password
No UoM account? Click here to register a guest account.
Have you forgotten your guest credentials?
Home
Minerva Access
Medicine, Dentistry & Health Sciences
Melbourne Medical School
Medicine (RMH)
Medicine (RMH) - Research Publications
No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score-matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP)